Revance Therapeutics Market Cap

Solvay has a market cap or net worth of €2.93 billion as of August 6, 2025. Its market cap has decreased by -16.25% in one year.

Market Cap

2.93B

Enterprise Value

4.87B

Revenue

4.95B

Ranking

n/a

PE Ratio

21.04

Stock Price

$28.10

Market Cap Chart

Since January 5, 1993, Solvay's market cap has increased from 2.38B to 2.93B, an increase of 22.85%. That is a compound annual growth rate of 0.63%.

Market Cap History

Date	Market Cap	% Change
Aug 5, 2025	2.94B	-9.71%
Dec 31, 2024	3.25B	10.73%
Dec 29, 2023	2.94B	-70.01%
Dec 30, 2022	9.79B	-7.14%
Dec 31, 2021	10.54B	5.23%
Dec 31, 2020	10.02B	-5.98%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Erste Group Bank AG	31.83B
VERBUND AG	23.10B
OMV Aktiengesellschaft	14.46B
Strabag SE	9.45B
BAWAG Group AG	8.63B
Raiffeisen Bank International AG	8.14B
Telekom Austria AG	6.06B
Andritz AG	6.05B

Market Cap Rankings